Possible role of methotrexate in trimethoprim-sulfamethoxazole-induced acute megaloblastic anemia. 1984

M Dan, and I Shapira

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000748 Anemia, Macrocytic Anemia characterized by larger than normal erythrocytes, increased mean corpuscular volume (MCV) and increased mean corpuscular hemoglobin (MCH). Anemias, Macrocytic,Macrocytic Anemia,Macrocytic Anemias
D000749 Anemia, Megaloblastic A disorder characterized by the presence of ANEMIA, abnormally large red blood cells (megalocytes or macrocytes), and MEGALOBLASTS. Anemias, Megaloblastic,Megaloblastic Anemia,Megaloblastic Anemias
D013420 Sulfamethoxazole A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208) Sulfamethylisoxazole,Gantanol,Sulfisomezole,Sulphamethoxazole

Related Publications

M Dan, and I Shapira
June 1981, Annals of internal medicine,
M Dan, and I Shapira
April 1974, Ugeskrift for laeger,
M Dan, and I Shapira
December 2017, Journal of pharmacy practice,
M Dan, and I Shapira
September 1999, Archives of pathology & laboratory medicine,
M Dan, and I Shapira
November 2004, The Annals of pharmacotherapy,
M Dan, and I Shapira
February 2011, Ear, nose, & throat journal,
M Dan, and I Shapira
August 1989, Annals of internal medicine,
M Dan, and I Shapira
December 1987, Journal of the American Academy of Dermatology,
M Dan, and I Shapira
September 1966, British medical journal,
Copied contents to your clipboard!